share_log

HC Wainwright & Co. Reiterates Buy on Citius Pharma, Maintains $4 Price Target

Benzinga ·  Aug 10, 2023 12:02

HC Wainwright & Co. analyst Vernon Bernardino reiterates Citius Pharma (NASDAQ:CTXR) with a Buy and maintains $4 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment